Search alternatives:
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
1 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
1 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
901
-
902
-
903
TGF-α decreased the percentage of motile cells.
Published 2009“…TGF-α caused significant decreases compared to pretreatment and aCSF. **P<0.01. …”
-
904
Cediranib therapy decreases tumor blood volume.
Published 2013“…<p>(left) After 2–3 days of treatment, a statistically significant (p<0.01) difference in the rCBV (±SEM) was observed between cediranib and control groups with a 16.5±2.2% decrease for cediranib treated animals and a 14.1±2.3% increase for control animals. …”
-
905
-
906
Anti-TGFβ antibody decreased osteoclast numbers and <i>in vitro</i> osteoclastogenesis.
Published 2013“…<p><b>Panel a:</b> Boxplot of number of TRAP positive osteoclasts per millimeter of bone surface in MBA-MB-231 tumor-bearing tibiae, showing significantly decreased osteoclasts upon 1D11 treatment, compared to 13C4. …”
-
907
-
908
-
909
-
910
-
911
-
912
-
913
ku0063794 but not rapamycin decreased the TRPC6 mRNA levels in podocytes.
Published 2014“…<p>(A) ku0063794 (2 µmol/l) or rapamycin (50 nmol/l) was applied to evaluate the effects of mTORC1 and mTORC2 on TRPC6 in podocytes. …”
-
914
Decreased cell number and size in AF flies.
Published 2007“…There was more than 20% reduction in wing area in AF (B; n = 16, <i>p</i><0.01), that is not able to be fully compensated by a corresponding increase in cell density (C and D; n = 16, <i>p</i><0.01). …”
-
915
-
916
-
917
-
918
Laquinimod prevents EAE and decreases encephalitogenicity of T cells.
Published 2012“…<p>DBA/1 (A) mice and C57BL/6 mice (B) were treated daily with laquinimod (25 mg/kg, n = 6/group) or vehicle (water, n = 6/group) starting from the day of immunization with rMOG 1-125 (DBA/1) or MOG p35-55 (C57BL/6). …”
-
919
-
920